Ticker LaunchIPO · SDGR
Schrodinger, Inc.
Schrodinger, Inc. (SDGR) priced its initial public offering on Feb 6, 2020 at $17.00 per share, above its $14.00–$16.00 range, raising $202M, and listed on Nasdaq Global Select. WilmerHale and Richards, Layton & Finger advised the company and Cooley advised the underwriters.
Schrodinger, Inc. sells a physics-based computational software platform used to discover molecules for drug development and materials applications. Customers include biopharmaceutical and industrial companies, academic institutions and government laboratories, and it also runs collaborative and internal drug discovery programs.
- Status
- IPO
- Ticker
- SDGR
- Exchange
- Nasdaq Global Select
- Priced
- Feb 6, 2020
- IPO price
- $17.00
- Price range
- $14.00–$16.00
- Raised
- $202M
- First filed
- Jan 10, 2020
- Company counsel
- WilmerHale and Richards, Layton & Finger
- Underwriters' counsel
- Cooley
- Sector
- Biotech & pharma
- Country / state
- NY
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jan 10, 2020
- Latest amendment Jan 27, 2020
- Final prospectus (424B4) Feb 6, 2020
- All filings on EDGAR CIK 1490978
Other Biotech & pharma IPOs in 2020
- Revolution Medicines, Inc.RVMD · Feb 13, 2020 · $238M
- Beam Therapeutics Inc.BEAM · Feb 7, 2020 · $180M
- PPD, Inc.PPD · Feb 6, 2020 · $1.62B
- Arcutis Biotherapeutics, Inc.ARQT · Jan 31, 2020 · $159.4M
- Annovis Bio, Inc.ANVS · Jan 30, 2020 · $12M
- Black Diamond Therapeutics, Inc.BDTX · Jan 30, 2020 · $201.1M